Listen to The Lancet Respiratory Medicine

Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.

Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.

Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.

Emma Grainger, Editor-in-Chief of  The Lancet Respiratory Medicine , discusses the January issue and plans to celebrate the 10-year anniversary of the journal.

Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis.

Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD.

Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study.

Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.

Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection.

Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved.

Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection.

Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53.

Ruvim Izickson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older.

Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research.

Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients.

Daniel Altmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes.

Comment author Michael Kreuter discusses a series of papers published in the Lancet and the Lancet Respiratory Medicine on interstitial lung disease.

Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure.

Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries.

Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma.

Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis.

Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease.

Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia.

Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome.

Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis